J. Symoens
About
In The Last Decade
J. Symoens
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 109
- Epidemiology 281
- Infectious Diseases 197
- Immunology 163
- Molecular Biology 145
- Endocrinology, Diabetes and Metabolism 143
Countries citing papers authored by J. Symoens
This map shows the geographic impact of J. Symoens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Symoens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Symoens more than expected).
Fields of papers citing papers by J. Symoens
This network shows the impact of papers produced by J. Symoens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Symoens. The network helps show where J. Symoens may publish in the future.
Co-authorship network of co-authors of J. Symoens
This figure shows the co-authorship network connecting the top 25 collaborators of J. Symoens. A scholar is included among the top collaborators of J. Symoens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Symoens. J. Symoens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 27 | |
| 6 | 199 | |
| 7 | Antihypertensive properties of ketanserin (R 41 468). | 30 |
| 8 | 128 | |
| 9 | 7 | |
| 10 | 19 | |
| 11 | 15 | |
| 12 | 108 | |
| 13 | [Immunopharmacology of levamisole]. | 2 |
| 14 | 30 | |
| 15 | 21 | |
| 16 | Levamisole in the modulation of the immune response: the current experimental and clinical state. | 224 |
| 17 | 19 | |
| 18 | [Therapy of systemic candidiasis using miconazol]. | 18 |
| 19 | 3 | |
| 20 | Pathogenesis and consequences of iron deficiency in the piglet. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.